Literature DB >> 20567970

Impaired wound healing and bilateral mastectomy flap necrosis in a patient with locally advanced breast cancer after neoadjuvant Paclitaxel with bevacizumab.

Valentina Lazzati, Justyna Zygoń, Visnu Lohsiriwat, Paolo Veronesi, Jean Yves Petit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20567970     DOI： 10.1007/s00266-010-9535-5

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN： 0364-216X            Impact factor:   2.326


× No keyword cloud information.
  4 in total

1.  Impaired wound healing secondary to bevacizumab.

Authors:  Ji W Ahn; Doaa Shalabi; Lilia M Correa-Selm; Bahar Dasgeb; Neda Nikbakht; Jisun Cha
Journal:  Int Wound J       Date:  2019-05-21       Impact factor: 3.315

Review 2.  Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.

Authors:  Efstathios T Pavlidis; Theodoros E Pavlidis
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

3.  Impaired wound healing and expansion of a large ulcer after bevacizumab with paclitaxel for skin metastases from breast cancer: report of a case.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Akihiro Nakajo; Hideo Arima; Yoshiaki Shinden; Tetsuya Ijichi; Yuka Eguchi; Hiroshi Okumura; Yoshikazu Uenosono; Hiroshi Kurahara; Sumiya Ishigami; Shoji Natsugoe
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549

4.  Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

Authors:  Mayu Ono; Tokiko Ito; Toshiharu Kanai; Koichi Murayama; Hiroshi Koyama; Kazuma Maeno; Yasuhiro Mochizuki; Asumi Iesato; Toru Hanamura; Toshihiro Okada; Takayuki Watanabe; Ken-Ichi Ito
Journal:  Onco Targets Ther       Date:  2013-10-07       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.